From: Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery
Variables | Cases, n (%) |
---|---|
Age(years) | |
 ≤ 54 | 73 (71.6) |
  > 54 | 29 (28.4) |
Surgical method | |
 Laparoscope | 82 (80.4) |
 Laparotomy | 20 (19.6) |
Postoperative treatment | |
 None | 10 (9.8) |
 Chemotherapy | 40 (39.2) |
 Chemo plus radiotherapy | 52 (51.0) |
Ovarian status | |
 Ovarian transposition | 23 (22.5) |
 Ovariectomy | 79 (77.5) |
Intraoperative blood loss(ml) | |
  ≤ 250 | 76 (74.5) |
  > 250 | 26 (25.5) |
Perioperative complications | |
 Negative | 76 (74.5) |
 Positive | 26 (25.5) |
Pathological type | |
 Squamous cell carcinoma | 80 (78.4) |
 Adenocarcinoma | 16 (15.7) |
 Adeno-squamous carcinoma | 6 (5.9) |
Tumor size (cm) | |
  ≤ 4 | 61 (59.8) |
  > 4 | 41 (40.2) |
LNR | |
  ≤ 0.3 | 79 (77.5) |
  > 0.3 | 23 (22.5) |
DSI | |
  ≤ 1/2 | 10 (9.8) |
  > 1/2 | 92 (90.2) |
LVSI | |
 Positive | 59 (57.8) |
 Negative | 43 (42.3) |
Vagina margin | |
 Positive | 43 (42.3) |
 Negative | 59 (57.8) |
Parametrium | |
 Positive | 12 (11.8) |
 Negative | 90(88.2) |
NLR | |
  ≤ 3.8 | 88(86.3) |
  > 3.8 | 14 (13.7) |